MYLAN MT 7 MYLAN MT 7 (Memantine Hydrochloride Extended-Release 7 mg)
Pill with imprint MYLAN MT 7 MYLAN MT 7 is Peach, Capsule-shape and has been identified as Memantine Hydrochloride Extended-Release 7 mg. It is supplied by Mylan Pharmaceuticals Inc..
Memantine is used in the treatment of alzheimer's disease and belongs to the drug class miscellaneous central nervous system agents. There is no proven risk in humans during pregnancy. Memantine 7 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN MT 7 MYLAN MT 7
Memantine Hydrochloride Extended-Release
- Imprint
- MYLAN MT 7 MYLAN MT 7
- Strength
- 7 mg
- Color
- Peach
- Size
- 14.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Miscellaneous central nervous system agents
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-5435
- Inactive Ingredients
-
corn starch,
sodium lauryl sulfate,
sucrose,
magnesium silicate,
titanium dioxide,
ferric oxide yellow,
ferric oxide red,
ammonia,
ferrosoferric oxide,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
More about memantine
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 57 Reviews
- Drug class: miscellaneous central nervous system agents
Consumer resources
- Patient Information
- Memantine (Advanced Reading)
- Memantine Tablets
- Memantine Extended-Release Capsules
- Memantine Solution
- Other brands
- Namenda, Namenda XR
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.